학술논문

Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Document Type
Article
Source
In: Nature Cancer. (Nature Cancer, April 2023, 4(4):502-515)
Subject
Language
English
ISSN
26621347